Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 234 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-02 2024-02-23 218376
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-09 2024-04-19 219177
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 100MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-23 2024-03-29 220465
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-01 2024-03-22 221096
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-08 2024-03-15 221717
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225770
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225779
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-26 225793
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Resolved 2023-03-09 2023-04-14 186586
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216699
APO-QUETIAPINE FUMARATE 100MG TABLET (IMMEDIATE RELEASE) Anticipated shortage 2024-01-19 2024-02-06 216702
APO-QUETIAPINE FUMARATE 200MG TABLET (IMMEDIATE RELEASE) Anticipated shortage 2024-01-19 2024-02-06 216705
APO-QUETIAPINE FUMARATE 300MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216708
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-10 245
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-17 249
APO-RIZATRIPTAN RPD 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-11 2020-07-06 490
APO-RIZATRIPTAN RPD 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-11 2018-09-11 493
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-13 2017-07-31 12689
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-08-08 2017-08-23 18546
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-03 2018-01-29 24277

Showing 2961 to 2980 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DOXY CAP 100MG 100MG CAPSULE Discontinued 2018-09-07 2018-09-29 60459
APO-LITHIUM CARBONATE 300MG CAPSULE Discontinued 2018-09-07 2018-09-15 60588
APO-MYCOPHENOLATE 250MG CAPSULE Discontinued 2018-09-07 2018-09-15 60637
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-SERTRALINE 100MG CAPSULE Discontinued 2018-09-08 2018-09-15 60781
APO-TEMAZEPAM 15MG CAPSULE Discontinued 2018-10-23 2019-01-14 65477
APO-TEMAZEPAM 30MG CAPSULE Discontinued 2018-10-23 2019-01-07 65482
IBUPROFEN LIQUID GEL CAPSULES 200MG CAPSULE Discontinued 2019-01-03 2019-01-03 71095
APO-CLINDAMYCIN 150MG CAPSULE Discontinued 2019-11-11 2019-11-11 98363
APO-DILTIAZ CD 300MG CAPSULE (CONTROLLED-DELIVERY) Discontinued 2019-02-01 2019-02-02 74366
APO-DILTIAZ TZ 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1064
APO-DILTIAZ TZ 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1069
APO-DILTIAZ TZ 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1072
APO-DILTIAZ TZ 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1075
APO-DILTIAZ TZ 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1078
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962

Showing 61 to 80 of 356